immunology, microbiology

The “tripledemic” shines a spotlight on viral interference, in which one infection can block another.

A clinical trial finds that the anticoagulant apixaban, which has been prescribed to help COVID-19 patients recover, is ineffective and in rare instances dangerous.

A high-fat diet induced changes to the animals’ vaginal microbiomes that boosted survival after exposure to the virus.

When fused to RSV, influenza A virus is better able to escape antibodies that usually neutralize it, an in vitro study finds.

The National Institute of Allergy and Infectious Diseases was not aware that the work involved a chimeric strain of SARS-CoV-2, STAT reports.

Researchers say they’re abandoning the project in its current form—one of several that aims to induce what’s known as mucosal immunity against SARS-CoV-2.

The results from two large clinical trials don't support the idea that supplements of the vitamin bolster immune defenses against SARS-CoV-2.

A bacterium that produces an insulin-like peptide can give mice type 1 diabetes, and infection with the microbe seems to predict the onset of the disease in humans, a study finds.

Immune defense genes in bacteria and archaea can identify viral proteins, a study finds, revealing similarities between the immune systems of prokaryotic and eukaryotic organisms.

Evidence thus far shows that pregnant people infected with SARS-CoV-2 are at higher risk for severe disease and death, as well as complications in their pregnancies.

The Scientist asks Brigham and Women’s Hospital infectious disease specialist Lindsey Baden about testing for prior infections.

Renewing the aging gut microbiome holds promise for preventing inflammatory brain and eye degeneration.

Researchers are going beyond fecal samples to understand how the patterns of commensal microbes in the gastrointestinal tract influence development and health.

A new program will provide 150 early-career scientists committed to advancing diversity, inclusion, and equity up to $8.6 million each.

A sugar that’s less abundant in the blood of people with diabetes binds to SARS-CoV-2’s spike protein and disrupts the virus’s ability to fuse with cells.  

Roseolovirus infection disrupts how the body trains immune cells not to attack it, a mouse study shows.

Two recent papers provide insight into possible risk factors for developing the chronic condition, including autoantibodies and diabetes.